Medimaps expands in the U.S. with the launch of TBS Osteo™ next-generation software for advanced bone microarchitecture assessment

Medimaps — the creator of TBS® (Trabecular Bone Score®), the global standard in bone microarchitecture assessment — is further expanding its presence in the US with the launch of its FDA-cleared next-generation TBS Osteo™ Advanced software. This milestone reflects the company’s commitment to advancing osteoporosis detection and bone health management in the US market with innovative solutions.